Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRON-CRT: Ferric Carboxymaltose in Heart Failure with CRT
NCT03380520Phase 4Completed
- Sponsor
- Hasselt University
- Start
- Oct 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in heart failure (HF), sponsored by Hasselt University. Started Oct 2017; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03380520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03380520.